GIRARDIS, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 40.750
EU - Europa 40.525
AS - Asia 19.675
SA - Sud America 3.025
Continente sconosciuto - Info sul continente non disponibili 822
AF - Africa 456
OC - Oceania 100
Totale 105.353
Nazione #
US - Stati Uniti d'America 39.786
IT - Italia 23.660
GB - Regno Unito 6.251
SG - Singapore 5.558
CN - Cina 5.070
SE - Svezia 3.130
HK - Hong Kong 2.546
BR - Brasile 2.222
VN - Vietnam 2.161
DE - Germania 1.568
FR - Francia 1.340
BD - Bangladesh 1.184
FI - Finlandia 1.013
RU - Federazione Russa 781
UA - Ucraina 777
KR - Corea 603
CA - Canada 527
TR - Turchia 509
IN - India 437
ID - Indonesia 427
NL - Olanda 427
BG - Bulgaria 337
AR - Argentina 285
MX - Messico 204
ES - Italia 163
IQ - Iraq 157
JP - Giappone 154
PL - Polonia 150
EC - Ecuador 126
IE - Irlanda 120
CO - Colombia 118
PK - Pakistan 107
CH - Svizzera 101
LT - Lituania 99
ZA - Sudafrica 93
AT - Austria 91
AU - Australia 88
IR - Iran 83
AE - Emirati Arabi Uniti 81
CL - Cile 70
VE - Venezuela 70
BE - Belgio 62
MY - Malesia 62
SA - Arabia Saudita 60
PH - Filippine 57
CZ - Repubblica Ceca 56
RO - Romania 55
MA - Marocco 52
EG - Egitto 51
CR - Costa Rica 49
DK - Danimarca 49
UZ - Uzbekistan 49
PY - Paraguay 45
TN - Tunisia 43
NP - Nepal 41
KE - Kenya 40
PE - Perù 40
TH - Thailandia 38
SI - Slovenia 36
JO - Giordania 33
AZ - Azerbaigian 32
HU - Ungheria 32
JM - Giamaica 32
NO - Norvegia 30
ET - Etiopia 29
KZ - Kazakistan 29
EU - Europa 28
GR - Grecia 27
LB - Libano 27
BO - Bolivia 26
HN - Honduras 24
PT - Portogallo 24
DO - Repubblica Dominicana 23
DZ - Algeria 23
RS - Serbia 20
UY - Uruguay 20
IL - Israele 18
AL - Albania 17
GT - Guatemala 17
NI - Nicaragua 17
OM - Oman 17
SN - Senegal 17
HR - Croazia 16
PS - Palestinian Territory 16
SY - Repubblica araba siriana 16
TT - Trinidad e Tobago 16
MD - Moldavia 15
TW - Taiwan 15
PA - Panama 14
PR - Porto Rico 14
BY - Bielorussia 12
EE - Estonia 12
NG - Nigeria 12
SC - Seychelles 12
GA - Gabon 11
GE - Georgia 11
SM - San Marino 11
NZ - Nuova Zelanda 10
QA - Qatar 10
BH - Bahrain 9
Totale 104.353
Città #
Southend 4.526
Ashburn 3.966
Santa Clara 3.878
Singapore 3.522
Fairfield 3.285
Hong Kong 2.487
Woodbridge 2.065
Chandler 1.946
Stockholm 1.806
Houston 1.648
San Jose 1.575
Jacksonville 1.434
Hefei 1.418
Milan 1.415
Council Bluffs 1.273
Seattle 1.232
Rome 1.086
Wilmington 1.054
Cambridge 1.049
Dearborn 1.034
London 1.008
Nyköping 956
Beijing 953
Ann Arbor 945
Los Angeles 693
Helsinki 689
Ho Chi Minh City 682
Bologna 671
Modena 630
Seoul 560
Hanoi 525
New York 525
Chicago 494
The Dalles 466
San Diego 423
Princeton 383
Florence 339
Dallas 331
Lauterbourg 321
Sofia 316
Jakarta 315
Torino 310
Turin 305
Buffalo 300
Moscow 267
Munich 256
Eugene 249
Naples 228
Shanghai 222
Catania 218
São Paulo 199
Boardman 196
Izmir 196
Palermo 189
Redwood City 184
Columbus 181
Salt Lake City 168
Verona 162
Padova 156
Toronto 156
Orem 139
Genova 134
Frankfurt am Main 130
Castelnuovo Rangone 125
Parma 123
Bari 120
Pisa 119
Genoa 117
Dublin 108
Napoli 107
Tokyo 107
Venezia 107
Reggio Nell'emilia 100
Phoenix 98
Des Moines 96
Nuremberg 96
Da Nang 95
Haiphong 95
Tampa 92
Warsaw 87
Guangzhou 86
Elk Grove Village 84
Trieste 81
Trento 80
Atlanta 78
Rio de Janeiro 76
Montreal 74
Mumbai 74
Brescia 72
Bremen 70
Miano 69
Mexico City 67
Amsterdam 66
Bolzano 63
Chennai 62
Monza 62
Norwalk 62
Paris 61
Reggio Emilia 61
Redondo Beach 58
Totale 61.667
Nome #
RICERCA DI MARCATORI PER LA DIAGNOSI DI INFEZIONE FUNGINA INVASIVAE (IFI) MEDIANTE APPROCCIO DIAGNOSTICO COMBINATO 15.276
EPIDEMIA DA INFEZIONE DI BURKHOLDERIA CEPACIA IN TERAPIA INTENSIVA: SORVEGLIANZA E CONTROLLO 4.254
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 1.939
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit 916
Acute renal failure and renal replacement therapy in the postoperative period of orthotopic liver transplant patients versus nonelective abdominal surgery patients 888
A Position Paper on IgM-Enriched Intravenous Immunoglobulin Adjunctive Therapy in Severe Acute Bacterial Infections: The TO-PIRO SCORE Proposal 822
Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit: The Oxygen-ICU Randomized Clinical Trial 774
Hospital staff education on severe sepsis/septic shock and hospital mortality: an original hypothesis 734
Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness 729
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 550
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 523
Oxygen in the critically ill: friend or foe? 502
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 480
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 469
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 446
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 446
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 440
Levosimendan in cardiac failure after subarachnoid hemorrhage. 438
Current gaps in sepsis immunology: new opportunities for translational research 438
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 420
Metabolic reprograming shapes neutrophil functions in severe COVID-19 419
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 413
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 408
A challenging case of pregnancy with placenta accreta and very rare irregular antibodies versus Cromer blood group system: a case report 404
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 389
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 383
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 381
Pain management after small bowel/multivisceral transplantation 377
Randomized, multicenter trial of lateral Trendelenburg versus semirecumbent body position for the prevention of ventilator-associated pneumonia 375
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 375
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 372
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 367
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 364
A new device for ultrasound-guided peripheral venous access 358
Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial 357
A one-year prospective study of refractory status epilepticus in Modena, Italy 357
Endotoxin activity levels as a prediction tool for risk of deterioration in patients with sepsis not admitted to the intensive care unit: a pilot observational study 356
Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: State-of-the-art and expert consensus 355
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 353
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 348
JLB: a flexible and effective device in critical patients. Review of clinical cases 347
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. 344
Effectiveness of sepsis bundle application in cirrhotic patients with septic shock: A single-center experience 342
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 342
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 341
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 341
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination 338
Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay 337
The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study) 337
Hypokalemia in Patients with COVID-19 337
Wernicke's encephalopathy in a malnourished surgical patient: a difficult diagnosis 335
A new technique for percutaneous dilatational tracheostomy (G-Trach): Preliminary experience in pigs 334
A Janus role for MerTK in the outcome of septic shock 331
Guide-wire replacement of a mini-midline catheter with a central venous catheter: A retrospective study on 63 cases 331
Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial 330
Purpura Fulminans and Septic Shock due to Capnocytophaga Canimorsus after Dog Bite: A Case Report and Review of the Literature 328
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 326
Impact of Pre-Analytical Time on the Recovery of Pathogens from Blood Cultures: Results from a Large Retrospective Survey 325
The prognostic importance of chronic end-stage diseases in geriatric patients admitted to 163 Italian ICUs 321
Adjunctive therapy with vitamin c and thiamine in patients treated with steroids for refractory septic shock: A propensity matched before-after, case-control study 319
Comment on [A modified goal-directed protocol improves clinical outcome in intensive care unit patients with septic shock patients: a randomized controlled trial.] 318
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial 317
Management of Sepsis in the First 24 Hours: Bundles of Care and Individualized Approach 316
Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August-September 2009. 313
Anestesia e disordini vasculo-polmonari nel paziente epatopatico: iter diagnostico e ruolo dello screening precoce 312
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 311
Effect of performance improvement programs on compliance with sepsis bundles and mortality: A systematic review and meta-analysis of observational studies 309
Early inspiratory effort assessment by esophageal manometry early predicts noninvasive ventilation outcome in de novo respiratory failure: a pilot study. 309
Peritoneal dialysis in the time of coronavirus disease 2019 308
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 307
Inspiratory effort and respiratory mechanics in spontaneously breathing patients with acute exacerbation of idiopathic pulmonary fibrosis: a retrospective matched control study. 303
CYTOREDUCTIVE SURGERY AND HIPEC IN A 14 YEARS OLD PATIENT WITH PERITONEAL RECURRENCE OF ADENOCARCINOMA OF THE RIGHT COLON 301
Muscle perfusion and oxygen consumption by near-infrared spectroscopy in septic-shock and non-septic-shock patients 299
Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol 298
World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections 291
Incidence and clinical outcomes of ventilator-associated pneumonia in liver transplant and non-liver transplant surgical patients. 289
Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock 289
Characteristics and outcome predictors of patients involved in an outbreak of Burkholderia cepacia complex 289
Case report of a patient who survived after cardiac arrest and cardiogenic shock by anaphylactic reaction to gadolinium during magnetic resonance imaging 289
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study 288
Mortality in Patients With Septic Shock by Multidrug Resistant Bacteria: Risk Factors and Impact of Sepsis Treatments 286
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 285
PSP/reg: a new stone in sepsis biomarkers? 284
The aPC treatment improves microcirculation in severe sepsis/septic shock syndrome 283
Intra-abdominal hypertension in nonelective surgery: A preliminary report 282
Bronchoalveolar lavage (BAL) and supplementation with exogenous surfactant in adults with acute respiratory distress syndrome (ARDS) 281
Use of recombinant factor VIIa in thrombocytopenic patient with spontaneous intracerebral haemorrhage. 281
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 279
Whole-genome sequencing reveals host factors underlying critical COVID-19 275
Increased Plasma Levels of Mitochondrial DNA and Normal Inflammasome Gene Expression in Monocytes Characterize Patients With Septic Shock Due to Multidrug Resistant Bacteria 275
Erratum to: The Intensive Care Global Study on Severe Acute Respiratory Infection (IC‑GLOSSARI): a multicenter, multinational, 14-day inception cohort study (Intensive Care Medicine, (2016), 42, 5, (953), 10.1007/s00134-016-4317-4) 273
Never Give Up: lesson learned from a severe COVID-19 patient. 272
Delayed upper airway obstruction following a retropharyngeal haematoma after minor head trauma. 271
Trends in ventilator-associated pneumonia: Impact of a ventilator care bundle in an Italian tertiary care hospital intensive care unit 270
Procalcitonin-guided antibiotic therapy: an expert consensus 267
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 267
University of Modena Experience With Liver Grafts From Donation After Circulatory Death: What Really Matters in Organ Selection? 265
Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure 265
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions 265
Immune System Dysfunction and Multidrug-resistant Bacteria in Critically Ill Patients: Inflammasones and Future Perspectives 263
Totale 57.226
Categoria #
all - tutte 365.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 365.659


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.421 0 0 686 462 313 404 512 486 856 550 1.058 1.094
2022/20238.797 953 864 675 722 869 992 390 828 1.016 339 585 564
2023/20246.790 461 553 541 724 1.052 526 567 785 222 249 361 749
2024/202515.022 569 379 306 1.147 2.709 2.256 902 886 1.836 960 1.298 1.774
2025/202628.497 1.679 1.085 2.498 3.044 3.380 1.486 3.281 1.487 4.162 2.545 2.170 1.680
2026/20274.092 1.062 2.867 163 0 0 0 0 0 0 0 0 0
Totale 105.353